Insider Stock Trading History of Haluska Frank


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Haluska Frank since year 2005. The trader's CIK number is 1494892. At the time of this reporting, Haluska Frank is the SVP, Clinical R&D, CMO of Ariad Pharmaceuticals Inc . (stock ticker symbol ARIA). See this page for all insider trading activities at Ariad Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Haluska Frank since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-04-29 ARIA Ariad Pharmaceuticals Inc Option Ex 17,334 .00 0
2016-03-19 ARIA Ariad Pharmaceuticals Inc Option Ex 6,500 .00 0
2016-03-21 ARIA Ariad Pharmaceuticals Inc Sale 3,575 6.47 23,115
2016-03-03 ARIA Ariad Pharmaceuticals Inc Sale 10,588 6.11 64,735
2016-03-01 ARIA Ariad Pharmaceuticals Inc Option Ex 19,250 .00 0
2016-02-01 ARIA Ariad Pharmaceuticals Inc Sale 16,133 4.81 77,583
2016-02-01 ARIA Ariad Pharmaceuticals Inc Option Ex 29,333 .00 0
2015-09-28 ARIA Ariad Pharmaceuticals Inc Sale 5,500 6.46 35,502
2015-09-24 ARIA Ariad Pharmaceuticals Inc Option Ex 10,000 .00 0
2015-07-15 ARIA Ariad Pharmaceuticals Inc Option Ex 8,000 .00 0
2015-07-16 ARIA Ariad Pharmaceuticals Inc Sale 4,400 8.54 37,575
2015-03-20 ARIA Ariad Pharmaceuticals Inc Sale 3,575 8.85 31,635
2015-03-20 ARIA Ariad Pharmaceuticals Inc Option Ex 6,000 .00 0
2015-03-19 ARIA Ariad Pharmaceuticals Inc Option Ex 6,500 .00 0
2015-03-23 ARIA Ariad Pharmaceuticals Inc Sale 3,300 8.55 28,228
2015-02-02 ARIA Ariad Pharmaceuticals Inc Sale 16,134 6.33 102,112
2015-02-02 ARIA Ariad Pharmaceuticals Inc Option Ex 29,334 .00 0
2014-07-15 ARIA Ariad Pharmaceuticals Inc Option Ex 8,000 .00 0
2014-04-02 ARIA Ariad Pharmaceuticals Inc Sale 3,400 8.21 27,917
2014-04-01 ARIA Ariad Pharmaceuticals Inc Option Ex 8,500 .00 0
2014-03-21 ARIA Ariad Pharmaceuticals Inc Sale 2,400 7.89 18,940
2014-03-19 ARIA Ariad Pharmaceuticals Inc Option Ex 6,500 .00 0
2014-03-20 ARIA Ariad Pharmaceuticals Inc Option Ex 6,000 .00 0
2013-12-18 ARIA Ariad Pharmaceuticals Inc Option Ex 12,750 .00 0
2013-12-19 ARIA Ariad Pharmaceuticals Inc Sale 5,100 5.14 26,214
2013-07-18 ARIA Ariad Pharmaceuticals Inc Sale 6,400 19.79 126,643
2013-07-15 ARIA Ariad Pharmaceuticals Inc Option Ex 16,000 .00 0
2013-04-01 ARIA Ariad Pharmaceuticals Inc Option Ex 8,500 .00 0
2013-04-02 ARIA Ariad Pharmaceuticals Inc Sale 3,400 18.04 61,339
2013-03-25 ARIA Ariad Pharmaceuticals Inc Sale 5,333 18.88 100,671
2013-03-22 ARIA Ariad Pharmaceuticals Inc Option Ex 13,333 .00 0
2013-03-22 ARIA Ariad Pharmaceuticals Inc Sale 2,400 19.46 46,694
2013-03-20 ARIA Ariad Pharmaceuticals Inc Option Ex 6,000 .00 0
2012-12-18 ARIA Ariad Pharmaceuticals Inc Option Ex 12,750 .00 0
2012-05-02 ARIA Ariad Pharmaceuticals Inc Sale 3,000 17.00 51,000
2012-05-02 ARIA Ariad Pharmaceuticals Inc Option Ex 3,000 2.39 7,170
2012-04-01 ARIA Ariad Pharmaceuticals Inc Option Ex 8,500 .00 0
2012-04-03 ARIA Ariad Pharmaceuticals Inc Sale 4,250 16.18 68,765
2012-03-26 ARIA Ariad Pharmaceuticals Inc Sale 3,000 16.00 48,000
2012-03-26 ARIA Ariad Pharmaceuticals Inc Option Ex 3,000 2.39 7,170
2012-03-22 ARIA Ariad Pharmaceuticals Inc Option Ex 13,333 .00 0
2012-03-23 ARIA Ariad Pharmaceuticals Inc Sale 6,667 15.41 102,718
2012-03-19 ARIA Ariad Pharmaceuticals Inc Option Ex 30,000 .00 0
2012-03-20 ARIA Ariad Pharmaceuticals Inc Sale 15,000 15.02 225,240
2012-02-21 ARIA Ariad Pharmaceuticals Inc Option Ex 4,500 2.39 10,755
2012-02-21 ARIA Ariad Pharmaceuticals Inc Sale 4,500 14.51 65,277
2011-03-22 ARIA Ariad Pharmaceuticals Inc Option Ex 13,334 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Haluska Frank (SVP, Clinical R&D, CMO of Ariad Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.